Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. (source: Medical News Today) – RSS news feeds and Widgets on Feedzilla.com

Excerpt from:
Merck Launches SAFLUTAN(R) (tafluprost) In International Markets (source: Medical News Today)

Related posts:

1. Merck Sharp & Dohme Launches SAFLUTAN™ (tafluprost) in International Markets WHITEHOUSE STATION, N.J., U.S.A.--(BUSINESS WIRE)--Merck Sharp & Dohme (MSD) has...
2. Merck Launches SAFLUTAN® (tafluprost) in International Markets WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. has launched SAFLUTAN...
3. Resumen: Merck Sharp & Dohme lanza SAFLUTAN TM (tafluprost) en los mercados internacionales WHITEHOUSE STATION, Nueva Jersey, EE.UU.--(BUSINESS WIRE)--MerckPam Eisele, +1 908–423–5042 ...
4. Merck Sharp & Dohme gibt internationalen Marktauftritt von SAFLUTAN™ (Tafluprost) bekannt WHITEHOUSE STATION, New Jersey, USA--(BUSINESS WIRE)--Merck Sharp & Dohme (MSD)...
5. Merck Sharp & Dohme lancia SAFLUTAN™ (Tafluprost) sui mercati internazionali WHITEHOUSE STATION, New Jersey, USA--(BUSINESS WIRE)--Merck Sharp & Dohme (MSD)...

Related posts brought to you by Yet Another Related Posts Plugin.

Tags | bird flu, countries, medical, news-feeds, next-several, other-countries, over-the-next, pending-regulatory, united-kingdom